Fig. 2

Percentage of tumor cells with androgen receptor immunohistochemical nuclear staining for the tamoxifen cohort (A) and the tamoxifen + fluoxymesterone cohort (B)
Percentage of tumor cells with androgen receptor immunohistochemical nuclear staining for the tamoxifen cohort (A) and the tamoxifen + fluoxymesterone cohort (B)